Bcl-2 Cancer Research Results
Bcl-2, B-cell CLL/lymphoma 2: Click to Expand ⟱
| Source: HalifaxProj (inhibit)
CGL-Driver Genes |
| Type: Antiapoptotic
Oncogene |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL, the pro-apoptotic proteins represented by BAX and Bak, and the pro-apoptotic BH3-only proteins represented by BAD and BID.
Since the expression of Bcl-2 protein in tumor cells is much higher than that in normal cells, inhibitors targeting it have little effect on normal cells.
|
PC, Pancreatic Cancer: Click to Expand ⟱
Pancreatic Cancer: Hypoxia (low oxygen tension) is commonly found in solid tumors. Hypoxia-inducible factor-1 (HIF-1),is a key mediator of the cellular response to hypoxia and is overexpressed in a wide variety of solid tumors, including pancreatic cancer.
Nanog is highly expressed in CSCs compared to normal cells [93–97]
HIF-1↑
|
Scientific Papers found: Click to Expand⟱
Apoptosis↑, TumCCA↑, HSP27↓, p‑Akt↓, proCasp3↑, proCasp9↑, Bcl-2↝, BAX↝, eff↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
p‑Akt↓, 1, Apoptosis↑, 1, BAX↝, 1, Bcl-2↝, 1, proCasp3↑, 1, proCasp9↑, 1,
Protein Folding & ER Stress ⓘ
HSP27↓, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1,
Total Targets: 9
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-2, B-cell CLL/lymphoma 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:21 Cells:% prod#:% Target#:27 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page